Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Felices

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Seminars in Immunology|September 9, 2017
Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapyZachary B Davis, Daniel A Vallera, Jeffrey S Miller, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2009
Tec kinase Itk in gammadeltaT cells is pivotal for controlling IgE production in vivoMartin Felices, Catherine C Yin, Yoko Kosaka, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 10, 2016
Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linkerJoerg U Schmohl, Martin Felices, Elizabeth Taras, et al.
Frontiers in Immunology|January 23, 2018
Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A ReviewLocke D Uppendahl, Carly M Dahl, Jeffrey S Miller, et al.
Immunological Reviews|February 13, 2014
The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT)Bree Foley, Martin Felices, Frank Cichocki, et al.
Immunological Reviews|March 18, 2009
The Tec kinases Itk and Rlk regulate conventional versus innate T-cell developmentAmanda L Prince, Catherine C Yin, Megan E Enos, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 15, 2016
Generation of BiKEs and TriKEs to Improve NK Cell-Mediated Targeting of Tumor CellsMartin Felices, Todd R Lenvik, Zachary B Davis, et al.
Frontiers in Immunology|August 9, 2021
Activation of ADAM17 by IL-15 Limits Human NK Cell ProliferationHemant K Mishra, Kate J Dixon, Nabendu Pore, et al.
Oncotarget|September 22, 2016
Tetraspecific scFv construct provides NK cell mediated ADCC and self-sustaining stimuli via insertion of IL-15 as a cross-linkerJoerg U Schmohl, Martin Felices, Deborah Todhunter, et al.
Heliyon|October 22, 2020
Therapeutic effect of TRC105 and decitabine combination in AML xenograftsJune Baik, Martin Felices, Ashley Yingst, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Seminars in Immunology|September 9, 2017
Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapyZachary B Davis, Daniel A Vallera, Jeffrey S Miller, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 7, 2009
Tec kinase Itk in gammadeltaT cells is pivotal for controlling IgE production in vivoMartin Felices, Catherine C Yin, Yoko Kosaka, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 10, 2016
Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linkerJoerg U Schmohl, Martin Felices, Elizabeth Taras, et al.
Frontiers in Immunology|January 23, 2018
Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A ReviewLocke D Uppendahl, Carly M Dahl, Jeffrey S Miller, et al.
Immunological Reviews|February 13, 2014
The biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT)Bree Foley, Martin Felices, Frank Cichocki, et al.
Immunological Reviews|March 18, 2009
The Tec kinases Itk and Rlk regulate conventional versus innate T-cell developmentAmanda L Prince, Catherine C Yin, Megan E Enos, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 15, 2016
Generation of BiKEs and TriKEs to Improve NK Cell-Mediated Targeting of Tumor CellsMartin Felices, Todd R Lenvik, Zachary B Davis, et al.
Frontiers in Immunology|August 9, 2021
Activation of ADAM17 by IL-15 Limits Human NK Cell ProliferationHemant K Mishra, Kate J Dixon, Nabendu Pore, et al.
Oncotarget|September 22, 2016
Tetraspecific scFv construct provides NK cell mediated ADCC and self-sustaining stimuli via insertion of IL-15 as a cross-linkerJoerg U Schmohl, Martin Felices, Deborah Todhunter, et al.
Heliyon|October 22, 2020
Therapeutic effect of TRC105 and decitabine combination in AML xenograftsJune Baik, Martin Felices, Ashley Yingst, et al.
Pageof 8